CLINICAL_TRIALS
trial_result
· 2019-10-09
Clinical Trial Update: An Efficacy and Safety Study of Fremanezumab in Adults With Migraine [Phase 3]
Summary
Phase 3 trial assessing fremanezumab for migraine prophylaxis in adults completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Migraine Prophylaxis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-09